GlassScriptPhysician profile
Jennifer Lynn Mitchell
NPI 1841939063
$1,152.67
in general payments reported to CMS, 2019-2025
14 companies · $34.66 in 2025
The $34.66 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,064 · 2023: $16.11 · 2024: $37.51 · 2025: $34.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $88.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $88.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $347.16 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $315.44 | 2022 | |
| Brainsway USA INC | $103.15 | 2022 | |
| Sunovion Pharmaceuticals INC. | $74.86 | 2022 | |
| Vanda Pharmaceuticals INC. | $65.04 | 2022 | |
| Indivior INC. | $39.54 | 2022 | |
| Alkermes, INC. | $37.64 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.13 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $34.96 | 2022 | |
| Neurocrine Biosciences, INC. | $31.35 | 2022 | |
| Janssen Pharmaceuticals, INC | $22.69 | 2022 | |
| Bausch Health US, LLC | $16.11 | 2023 | Aplenzin |
| Teva Pharmaceuticals USA, INC. | $15.47 | 2024 | Austedo Xr |
| Lundbeck LLC | $13.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.